Skip to main content
Premium Trial:

Request an Annual Quote

Richard Groves Goes to Turbo-Worx; Celera Appoints Steven Ruben VP of Protein Therapeutics; Pharmacia VP Named CEO of Celltech

NEW YORK, April 23 - Richard Groves has been named business development director for the new European office of life sciences grid computing provider TurboWorx, the New Haven, Conn., company said April 21.

 

Groves, who will be based in Oxford, UK, was previously business development director, Europe, for Argentys, formerly Blackstone Computing. He also was scientific service manager , and previously field scientist, of Genomica.  He has has held postdoctoral research fellowships  at the Ludwig Institute for Cancer Research as well as Oxford's department of Pharmacology.

 


Steven Ruben has been appointed vice president of protein therapeutics for Celera Genomics, the company said April 17.

 

Ruben, who will oversee the company's target validation efforts as well as protein chemistry, cell biology, and mass spectrometry research, comes to Celera from Rockville, Md., neighbor Human Genome Sciences. He was most recently vice president of research at HGS, where he worked for ten years.

 


 

Goran Ando has been named new CEO of UK biotech giant Celltech, which just acquired Oxford Glycosciences in a cash tender offer, the company said April 16.

 

Ando comes to Celltech from Pharmacia, where he was president of R&D until the company was acquired by Pfizer April 15. Ando has also served as director of R&D for Glaxo Group Research

 

Ando replaces Peter Fellner, the CEO of Celltech since 1990. Fellner will now serve as chairman of Celltech.

 

 

 

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.